Key takeaways
- Price from contribution margin per patient per month, not from what competitors charge.
- Cadence is a pricing lever. Twelve and twenty-four week commitments transform payback on long-latency therapies.
- A percentage-based platform caps your pricing power, because every price increase hands them a share.
- Bill on the ship event rather than the calendar, or a titrating therapy will misbill from the first dose change.
- If the platform sets your retail price, you do not have a pricing strategy at all.
Start from contribution, not from the market
The instinct is to look at what comparable brands charge and land nearby. That tells you what the market will bear, which is useful, but it does not tell you whether the business works.
Start instead from contribution margin per patient per month: retail price, minus medication and fulfillment, minus the platform's variable take, minus payment processing, minus any per-order fees. Then compare that against blended customer acquisition cost to see how many months it takes to pay back a patient.
That number determines everything else, including how much you can afford to spend on acquisition and therefore how fast you can grow.
Cadence is a pricing decision
Monthly billing feels like the default. For several categories it is actively the wrong choice.
Hair loss takes three to six months to show a visible result. A patient billed monthly is given an opportunity to quit every thirty days, throughout the entire period in which the therapy cannot yet be seen to work. A twelve or twenty-four week commitment, priced to make the longer term rational, aligns the billing cycle with the clinical one.
The same logic applies to sexual health, where pack-based fulfillment means a single shipment covers months, and to longevity memberships built around a review calendar rather than a monthly touchpoint.
Discount the commitment, not the product
There is a meaningful difference between lowering your price and pricing a longer commitment lower per month. The first trains patients to wait for discounts. The second buys retention with margin you were going to spend on churn anyway.
A typical structure prices the monthly plan at full rate, a twelve-week plan somewhat lower per month, and a twenty-four or fifty-two week plan lower again. The patient chooses the term; you get predictable revenue and a longer runway before the first churn decision.
Bill on the ship event, not the calendar
This is a pricing problem disguised as an infrastructure one. In a titrating therapy the dose changes over the patient's life, shipments can be gated by a check-in, and a pharmacy backorder can delay fulfillment.
A calendar-based subscription charges regardless. That produces charges for shipments that did not go out, which produces disputes, which threatens the merchant account itself in a category already coded high risk.
Billing tied to the fulfillment event, at the dose actually dispensed, removes an entire class of disputes and makes multi-month plans safe to sell.
Your platform's model caps your pricing power
If your platform takes a percentage of billings, every price increase you make hands them a share of it. Raising price from $249 to $299 under a 20% revenue share gives the platform an extra $10 a month per patient for doing nothing different.
Worse, if the platform sets the retail price, as some schedules do, you have no pricing strategy at all. You cannot test $299 against $249, cannot run a premium tier, cannot discount to win a channel, and cannot price by cohort. Your margin is assigned rather than built.
Under a flat fee the entire spread between your price and your fulfillment cost is yours, and the platform fee does not move when you raise price.
You set the price. We do not take a share of it
PharmaBro charges a published flat platform fee and a transaction fee that falls from 3% to 1.5% by tier. Zero revenue share and zero medication markup, so every dollar between your retail price and your fulfillment cost is yours.
The in-house rebill engine bills on the ship date at the dose dispensed, and handles multi-month plans as fulfillment-timed charges rather than calendar subscriptions, which is what makes twelve and twenty-four week commitments safe to sell.
Conclusion
Pricing a telehealth subscription is three decisions, not one: the number, the cadence, and the commitment structure.
Get contribution margin per patient first, then choose a cadence that matches how long the therapy actually takes to work, then price the commitment rather than discounting the product. And check that your platform lets you do all three, because some of them decide it for you.
Frequently asked questions
Should I bill monthly or quarterly?
It depends on how long the therapy takes to show results. Categories with a long latency, such as hair loss, benefit strongly from twelve and twenty-four week commitments, because monthly billing invites a cancellation decision every thirty days during the exact period the patient cannot yet see progress.
How much should I discount a longer commitment?
Enough that the longer term is clearly the rational choice, without training patients to expect discounts on the monthly plan. Model it against your payback period: if a twenty-four week commitment carries you past your break-even month, the discount is buying retention you would otherwise pay for in churn.
Can I change prices whenever I want?
On a flat-fee platform where you own the merchant account, yes. On a percentage model you can still change prices, but you are sharing the increase. On platforms where the schedule sets the retail price, you cannot change it at all, which is worth confirming before you sign.
References
Tobias LundHead of Growth
Came from performance marketing on the brand side. Now spends his time explaining why blended CAC is the only acquisition number that does not lie to you.